Page last updated: 2024-12-07

n(alpha)-acetyllysine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N(α)-acetyllysine is a post-translationally modified amino acid found in proteins. It is formed by the acetylation of the α-amino group of lysine residues. This modification can affect protein stability, structure, and function. N(α)-acetyllysine is particularly important in the regulation of histone proteins, which are involved in packaging and regulating DNA. Acetylation of histones can alter chromatin structure, making DNA more accessible for transcription. N(α)-acetyllysine is studied extensively to understand its role in gene regulation, cellular signaling, and disease. Its synthesis can occur through the action of histone acetyltransferases (HATs), which add acetyl groups to lysine residues. N(α)-acetyllysine can be removed by histone deacetylases (HDACs). The balance of HAT and HDAC activity plays a crucial role in regulating gene expression.'

N(alpha)-acetyllysine: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

acetyl-L-lysine : An N-acetyl-L-amino acid that is the N-acetyl derivative of L-lysine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

N(2)-acetyl-L-lysine : An acetyl-L-lysine where the acetyl group is located at the N(2)-posiiton. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID92907
CHEMBL ID1241437
CHEBI ID35704
SCHEMBL ID20529
MeSH IDM0042868

Synonyms (54)

Synonym
AKOS015837751
n(alpha)-acetyl-l-lysine
(2s)-2-(acetylamino)-6-aminohexanoic acid
n-alpha-acetyl-l-lysine
n-acetyl-l-lysine ,
n(2)-acetyl-l-lysine
CHEBI:35704 ,
n.alpha.-acetyllysine
6-amino-l-2-acetamidohexanoic acid
n.alpha.-acetyl-l-lysine
.alpha.-acetyl-l-lysine
nsc-353625
l-lysine, n2-acetyl-
n(alpha)-acetyllysine
1946-82-3
n2-acetyl-l-lysine
nalpha-acetyl-l-lysine
ac-lys-oh
(2s)-2-acetamido-6-aminohexanoic acid
BMSE000830
CHEMBL1241437
einecs 217-747-5
unii-7d44e6bn1b
nsc 353625
7d44e6bn1b ,
S3345
n2-acetyllysine
n|a-acetyl-l-lysine
EPITOPE ID:143648
n-acetyllysine
n-|a-acetyl-l-lysine
AM81903
SCHEMBL20529
n-alpha-acetyl-l-lysine (ac-l-lys-oh)
mfcd00008233
(s)-2-acetamido-6-aminohexanoic acid
lysine, n2-acetyl-, l-
n(.alpha.)-acetyl-l-lysine
acetyl-l-lysine
acetyl-lysine
J-012605
6-amino-l-2-acetamidohexanoate
n-a-acetyllysine
n-a-acetyl-l-lysine
HY-W048838
F10720
na-acetyl-l-lysine
AS-46851
Q27104319
CS-0101238
Z1255438452
DTXSID501036027
(2s)-6-amino-2-acetamidohexanoic acid
EN300-1699962
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
acetyl-L-lysineAn N-acetyl-L-amino acid that is the N-acetyl derivative of L-lysine.
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID513346Inhibition of wild-type Bacillus subtilis 168 1A1 lysine riboswitch 179 lysc assessed as reduction of beta-galactosidase activity at 5 mM after 3 hrs by lacZ reporter gene assay2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513343Binding affinity to Bacillus subtilis 168 1A1 lysine riboswitch 179 lysc by in-line probing assay2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513357Antibacterial activity against Bacillus subtilis 168 1A1 after 24 hrs by CLSI method2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (49)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (8.16)18.7374
1990's12 (24.49)18.2507
2000's23 (46.94)29.6817
2010's9 (18.37)24.3611
2020's1 (2.04)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.89 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (6.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other47 (94.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]